While AI may be the catalyst behind the recent wave of data company M&A, the market was ripe for consolidation.

An annual snapshot report tracks the record expansion and changing nature of the growing industry channel fueled by financial ...

IGF offers stable cash flow, global infrastructure exposure, and strong dividend potential amid rising investment trends. See ...

Datadog’s first quarter performance reflected strong customer demand for its cloud monitoring and security platform, as well ...

Jazz Pharmaceuticals plc is a Buy with its robust portfolio, potential FDA approvals, and innovative oncology treatments.

In an enterprise world drowning in dashboards, one truth keeps surfacing: Data isn’t the problem—product thinking is.

Artificial intelligence startups aren’t just chasing capital. They’re seeking deals for customer data.As my colleague Kevin ...

The US market is starting to look expensive again, so investors may be wondering which stocks to buy now against this backdrop. Regardless of where the markets are headed, investors may want to own ...

Nvidia Corporation (NASDAQ:NVDA) is one of the top 10 picks from Harvard University’s stock portfolio. As of the end of Q1 ...

Navratna PSU Stocks to Buy: A Navratna PSU stock, which just started trading as part of the 30-scrip Sensex pack, is catching the attention of investors and analysts alike. Analysts have placed their ...

Discover the comprehensive Portugal Data Center Market Portfolio Analysis, offering in-depth insights into existing and upcoming colocation data centers. This Excel database covers key locations, ...

According to InvestingPro data, analyst targets for the pharmaceutical giant range from $650 to $1,190, with the stock currently trading near $777. The firm highlighted Eli Lilly's metabolic portfolio ...